To our knowledge, this is the first successful description of bedaquiline's exposure-response relationship and may be used when considering dose optimization. Characterization of this relationship was possible by integrating quantitative information in existing clinical data using novel models.
No takes yet. Share an insight, caveat, or question.
Svensson et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: